02181.HK
Mabpharm Limited
HKSE · Healthcare · Biotechnology · CN
HKD 0.45
+0.00%Margins
Gross margin
85.6%
EBITDA margin
-0.7%
EBIT margin
-12.8%
Net margin
-8.0%
FCF margin
-6.0%
-45.6%
Return on equity
-6.2%
Return on assets
-23.7%
Return on invested capital
0.81x
Asset turnover
HKD 89.4M
Cash from operations
HKD 0.03
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Dec 1, 2025